FDA officials say different communication methods needed to ensure AI/ML transparency

More than two years after holding a public workshop on transparency in the artificial intelligence/machine learning (AI/ML) space, US Food and Drug Administration (FDA) officials have published an article in Nature magazine calling for a new communication approaches to ensure transparency for such products.